VE-cadherin may suppress inflammation depending on the phase of inflammation of rheumatoid arthritis
Modern Rheumatology · 2025
DOI: 10.1093/mr/roae107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Rheumatology, 2025. Verfasst von Shinichiro Nishimi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Cadherins, Antigens, CD, Inflammation. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Objectives
A disintegrin and metalloproteinase (ADAM)-15 and vascular endothelial (VE)-cadherin are involved in angiogenesis. We investigated the relationship between ADAM-15 and VE-cadherin expressions in rheumatoid arthritis (RA).
Methods
VE-cadherin concentrations in the serum of patients with RA were measured using the enzyme linked immunosorbent assay. We stimulated fibroblast-like synoviocytes (RA-FLS) with VE-cadherin and measured the vascular endothelial growth factor (VEGF) and inflammatory cytokine levels using ELISA. We also examined the correlation between serum VE-cadherin levels and DAS-28ESR, and used the Matrigel assay to examine VE-cadherin involvement in angiogenesis.
Results
Serum VE-cadherin levels were significantly higher in patients with RA than in healthy controls. A negative correlation was observed between VE-cadherin and DAS-28ESR. VEGF, chemokine ligand 16, intercellular adhesion molecule-1, and interleukin-8 levels in the supernatant of RA-FLS or human umbilical vein endothelial cells stimulated with VE-cadherin were significantly lower than those in the controls. The number of intercellular bridges formed by endothelial cells using Matrigel significantly decreased in RA synovial fluids from which VE-cadherin had been removed compared to synovial fluids treated with control immunoglobulin G.
Conclusion
VE-cadherin may have an inhibitory effect on inflammation depending on the phase of RA inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
- Department of Pathogenesis and Translational Medicine, Showa University Graduate School of Pharmacy, Tokyo, Japan.
ORCID-Profile: Shinichiro Nishimi
Zitieren
APA
Nishimi, S., Fukuse, S., Miwa, Y., Wakabayashi, K., & Isozaki, T. (2025). VE-cadherin may suppress inflammation depending on the phase of inflammation of rheumatoid arthritis. Modern Rheumatology. https://doi.org/10.1093/mr/roae107
Vancouver
Nishimi S, Fukuse S, Miwa Y, Wakabayashi K, Isozaki T. VE-cadherin may suppress inflammation depending on the phase of inflammation of rheumatoid arthritis. Modern Rheumatology. 2025. doi:10.1093/mr/roae107
BibTeX
@article{Nishimi2025,
author = {Nishimi, Shinichiro and Fukuse, Sayaka and Miwa, Yusuke and Wakabayashi, Kuninobu and Isozaki, Takeo},
title = {VE-cadherin may suppress inflammation depending on the phase of inflammation of rheumatoid arthritis},
journal = {Modern Rheumatology},
year = {2025},
doi = {10.1093/mr/roae107}
}
EUVIMED